Additionally, in the in vivo results, compound 4 inhibited the tumor proliferation by 48.4% compared to 29.28% for 5-FU, activated antioxidants (CAT, SOD and GSH) levels, and ameliorated hematological and biochemical parameters, as well as histopathological examinations. This evidence concerns the gene SOD1 and neoplasm.